Fadhil HR, Al-Jumaili AA, Al-Ani NA. Cost-effectiveness Analysis of Reference Infliximab (Remicade) Compared to its Biosimilar (Remsima) in Iraqi Patients with Rheumatoid Arthritis (Conference Paper )#. Iraqi Journal of Pharmaceutical Sciences . 2023;31(Suppl.):100-110. doi:10.31351/vol31issSuppl.pp100-110